1. Albertini,R.J., Castle,K.L. and Borcherding,W.R. (1982) T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl Acad. Sci. USA, 79, 6617–6621.
2. Cole,J. and Skopek,T.R. (1994) Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat. Res., 304, 33–105.
3. Hemminki,K. (1997) DNA adducts and mutations in occupational and environmental biomonitoring. Environ. Health Perspect., 105 (suppl. 4), 823–827.
4. Poirier,M.C. (1997) DNA adducts as exposure biomarkers and indicators of cancer risk. Environ. Health Perspect., 105 (suppl. 4), 907–912.
5. Wild,C.P. and Pisani,P. (1997) Carcinogen–DNA and carcinogen–protein adducts in molecular epidemiology. In Toniolo,P., Boffetta,P., Shuker,D.E.G., Rothman,N., Hulka,B. and Rearce,N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications no. 142, IARC, Lyon, pp. 143–158.Wild,C.P. and Pisani,P. (1997) Carcinogen–DNA and carcinogen–protein adducts in molecular epidemiology. In Toniolo,P., Boffetta,P., Shuker,D.E.G., Rothman,N., Hulka,B. and Rearce,N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications no. 142, IARC, Lyon, pp. 143–158.